Feed aggregator

Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva

Biospace news - Tue, 04/23/2024 - 02:00
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva 4/23/2024

European Commission approves Pfizer's EMBLAVEO® for patients with multidrug-resistant infections and limited treatment options

World Pharma News - Mon, 04/22/2024 - 10:00
Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO® (aztreonam-avibactam) for the treatment of adult patients with complicated intra-abdominal infections (cIAI), hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), and complicated urinary tract infections (cUTI), including pyelonephritis. It is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adult patients with limited treatment options.

Researchers develop a new way to safely boost immune cells to fight cancer

World Pharma News - Fri, 04/19/2024 - 10:00
Cancer is the monster of our society. Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped medical progress on developing treatment procedures that are less invasive while still highly effective.

Immunotherapy is on the rise as a possible solution. Immunotherapy involves harnessing the power of the body's immune system to fight against cancer cells.

Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US

Biospace news - Fri, 04/19/2024 - 02:00
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US 4/19/2024

FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies

Biospace news - Fri, 04/19/2024 - 02:00
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024

Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC

Biospace news - Fri, 04/19/2024 - 02:00
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024

Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring

Biospace news - Fri, 04/19/2024 - 02:00
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?

Biospace news - Fri, 04/19/2024 - 02:00
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Biospace news - Fri, 04/19/2024 - 02:00
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024

How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'

World Pharma News - Thu, 04/18/2024 - 10:00
A novel approach to drug discovery is enabling University of Birmingham researchers to overcome the 'valley of death', where projects fail due to the funding gap between original research and commercial investment.

The approach, detailed in a feature published in the April issue of Drug Discovery Today, has attracted more than £4m in industry funding, grants and industry awards, on the back of just £0.2m investment from the University's Dynamic Investment Fund (DIF).

Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market

Biospace news - Thu, 04/18/2024 - 02:00
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024

Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win

Biospace news - Thu, 04/18/2024 - 02:00
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024

Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition

Biospace news - Thu, 04/18/2024 - 02:00
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024

Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA

Biospace news - Thu, 04/18/2024 - 02:00
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch

Biospace news - Thu, 04/18/2024 - 02:00
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024

Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS

Biospace news - Thu, 04/18/2024 - 02:00
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024

Bioversity Program Preps Grads for Early-Career Life Science Roles

Biospace news - Thu, 04/18/2024 - 02:00
Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024

How to Deal With Layoff-Related Stress

Biospace news - Thu, 04/18/2024 - 02:00
How to Deal With Layoff-Related Stress 4/18/2024

Career Coach: How to Look Professional in Virtual Meetings

Biospace news - Thu, 04/18/2024 - 02:00
Career Coach: How to Look Professional in Virtual Meetings 4/18/2024

5 Top Companies Hiring Oncology Jobs

Biospace news - Thu, 04/18/2024 - 02:00
5 Top Companies Hiring Oncology Jobs 4/18/2024